Tempero, Margaret A.
10 papers on CoChatORCID 0000-0002-2777-9208
Most cited papers
- Verified
Whole genomes redefine the mutational landscape of pancreatic cancer
Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 2,642
- Verified
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 2,058
- Verified
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 2,019
- Verified
Pancreatic cancer
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 1,982
- Verified
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., et al. (2011) · Nature Medicine
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 1,967
- Verified
Randomized Phase III trial of Pegvorhyaluronidase Alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma
Van Cutsem, E., Tempero, M. A., Sigal, D., Oh, D.-Y., Fazio, N., Macarulla, T., Hitre, E., Hammel, P., Hendifar, A. E., Bates, S. E., et al. (2020) · Journal of Clinical Oncology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 499
- Verified
Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas
Zill, O. A., Greene, C., Sebisanovic, D., Siew, L. M., Leng, J., Vu, M., Hendifar, A. E., Wang, Z., Atreya, C. E., Kelley, R. K., et al. (2015) · Cancer Discovery
Cancer Genomics and DiagnosticsPancreatic and Hepatic Oncology Research
Cited by 282
- Verified
Leukocyte heterogeneity in pancreatic ductal adenocarcinoma: phenotypic and spatial features associated with clinical outcome
Liudahl, S. M., Betts, C. B., Sivagnanam, S., Morales-Oyarvide, V., da Silva, A., Yuan, C., Hwang, S., Grossblatt-Wait, A., Leis, K. R., Larson, W., et al. (2021) · Cancer Discovery
Pancreatic and Hepatic Oncology ResearchCancer Immunotherapy and Biomarkers
Cited by 164
- Verified
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Jiang, H., Torphy, R. J., Steiger, K., Hongo, H., Ritchie, A. J., Kriegsmann, M., Horst, D., Umetsu, S. E., Joseph, N. M., McGregor, K., et al. (2020) · Journal of Clinical Investigation
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 127
- Verified
Clinical Trials: Does One Size Really Fit All?
Tempero, M. (2023) · Journal of the National Comprehensive Cancer Network
Statistical Methods in Clinical TrialsEthics in Clinical Research
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free